The Deficit Reduction Act of 2005 (DRA) was created to cut Medicare spending and reduce reimbursement fraud. More recent provisions require that hospitals identify high-cost, high-volume healthcare-acquired conditions (HAC) that could have been prevented through the use of evidence-based guidelines. Often times, this means that hospitals are not paid for infections that could have been prevented.
Many of these DRA-classified conditions are transmitted through surgical sites and medical devices, including catheters, ventilators, endoscopes and implants. In order to avoid non-payment, hospitals are looking to better protect surgical surfaces and devices against a broad spectrum of microorganisms.
Hospital and other healthcare facilities have turned to Agion-treated medical devices and surfaces to limit patient exposure to dangerous bacteria and, ultimately, reduce the number of preventable infections that not only impact quality care, but also a hospital’s bottom line.